SLGL · Sol-Gel Technologies Ltd. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $17.26M | - | $5.43M | - | $594.0K | - | $3.52M | - | $928.0K |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | $4.65M | - | $2.44M | - | $5.31M | - | $2.38M | - | $6.93M |
| SG&A | - | $1.39M | - | $1.37M | - | $1.81M | - | $1.60M | - | $2.04M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | - | $11.23M | - | $1.62M | - | ($6.53M) | - | ($463.0K) | - | ($8.04M) |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | - | $11.61M | - | $1.98M | - | ($5.97M) | - | ($134.0K) | - | ($8.03M) |
| EPS - Basic | - | $4.17 | - | $0.70 | - | $2.20 | - | $3.50 | - | - |
| EPS - Diluted | - | $4.17 | - | $0.70 | - | $2.20 | - | $3.50 | - | - |
Balance Sheet
| Line item | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11.03M | $10.22M | $19.49M | $11.55M | $7.51M | $15.62M | $12.45M | $5.76M | $20.09M | $11.15M |
| Accounts Receivable | $1.97M | $10.04M | $3.60M | $6.06M | $377.0K | $2.21M | $62.0K | $10.18M | $13.06M | $956.0K |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $735.0K | $1.26M | $1.26M | $679.0K | $154.0K | $461.0K | $251.0K | $860.0K | $766.0K | $1.34M |
| Current Assets | $26.97M | $36.26M | $31.30M | $38.28M | $41.17M | $51.59M | $43.05M | $48.48M | $57.11M | $41.39M |
| Total Assets | $29.92M | $39.31M | $35.85M | $42.01M | $45.29M | $55.10M | $46.63M | $54.98M | $69.19M | $46.41M |
| Current Liabilities | $6.17M | $4.96M | $5.29M | $5.20M | $4.52M | $5.67M | $3.33M | $3.23M | $11.69M | $5.16M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $7.11M | $7.42M | $7.00M | $7.10M | $6.64M | $6.81M | $4.42M | $4.63M | $13.60M | $7.16M |
| Stockholders' Equity | $22.81M | $31.88M | $28.85M | $32.65M | $38.64M | $43.60M | $42.21M | $50.35M | $55.59M | $67.13M |
| Retained Earnings | ($237.01M) | ($228.08M) | ($230.88M) | ($224.67M) | ($220.30M) | ($209.76M) | ($193.06M) | ($183.87M) | ($178.14M) | ($193.46M) |
Cash Flow
| Line item | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - | - | - | - | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q4 '25 | Q2 '25 | Q4 '24 | Q2 '24 | Q4 '23 | Q2 '23 | Q4 '22 | Q2 '22 | Q4 '21 | Q2 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | 65.1% | - | 29.9% | - | -1098.8% | - | -13.2% | - | -866.6% |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | 67.3% | - | 36.4% | - | -1005.1% | - | -3.8% | - | -865.6% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | 26.9% | - | 44.9% | - | 894.3% | - | 67.7% | - | 747.1% |
| SG&A / Revenue | - | 8.0% | - | 25.2% | - | 304.5% | - | 45.5% | - | 219.5% |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | - | 29.5% | - | 4.7% | - | -10.8% | - | -0.2% | - | -17.3% |
| Return on equity | - | 36.4% | - | 6.1% | - | -13.7% | - | -0.3% | - | -12.0% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 4.37 | 7.32 | 5.92 | 7.36 | 9.10 | 9.10 | 12.93 | 15.03 | 4.88 | 8.03 |
| Quick ratio | 4.37 | 7.32 | 5.92 | 7.36 | 9.10 | 9.10 | 12.93 | 15.03 | 4.88 | 8.03 |
| Cash ratio | 1.79 | 2.06 | 3.69 | 2.22 | 1.66 | 2.76 | 3.74 | 1.79 | 1.72 | 2.16 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.31 | 1.23 | 1.24 | 1.29 | 1.17 | 1.26 | 1.10 | 1.09 | 1.24 | 0.69 |
| Liabilities / Assets | 0.24 | 0.19 | 0.20 | 0.17 | 0.15 | 0.12 | 0.09 | 0.08 | 0.20 | 0.15 |
| Efficiency | ||||||||||
| Asset turnover | - | 0.44 | - | 0.13 | - | 0.01 | - | 0.06 | - | 0.02 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | 212d | - | 407d | - | 1355d | - | 1056d | - | 376d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | 1.8x | - | 12.7x | - | 13.6x | - | 11.7x | - | - |
| P / B | - | 0.6x | - | 7.6x | - | 19.0x | - | 18.8x | - | - |
| P / S | - | 1.2x | - | 45.6x | - | 1392.3x | - | 269.5x | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | 217.7% | - | 814.6% | - | -83.1% | - | 279.1% | - | -18.1% |
| Revenue CAGR (3y) | - | 69.9% | - | 80.2% | - | -19.4% | - | -23.3% | - | - |
| Revenue CAGR (5y) | - | 72.4% | - | -7.0% | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | 591.5% | - | - | - | -1309.7% | - | 94.2% | - | -6.5% |
| Net income growth (YoY) | - | 487.6% | - | - | - | -4355.2% | - | 98.3% | - | -13.6% |
| EPS growth (YoY) | - | 495.7% | - | -68.2% | - | -37.1% | - | - | - | - |
| EPS CAGR (3y) | - | 6.0% | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -20.9% | -2.4% | -25.3% | -25.1% | -8.5% | -13.4% | -24.1% | -25.0% | 9.3% | 2.5% |
Peer comparison
Same SIC group: Pharmaceutical Preparations
Comparing Sol-Gel Technologies Ltd. against the 5 most active filers in the same SIC group.